Cargando…
cGMP becomes a drug target
Cyclic guanosine 3′,5′-monophosphate (cGMP) serves as a second messenger molecule, which regulates pleiotropic cellular functions in health and disease. cGMP is generated by particulate or soluble guanylyl cyclases upon stimulation with natriuretic peptides or nitric oxide, respectively. Furthermore...
Autores principales: | Schlossmann, Jens, Schinner, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281996/ https://www.ncbi.nlm.nih.gov/pubmed/22297800 http://dx.doi.org/10.1007/s00210-012-0730-6 |
Ejemplares similares
-
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
por: Schinner, Elisabeth, et al.
Publicado: (2011) -
Function of cGMP-dependent protein kinase II in volume expansion-induced diuresis
por: Schramm, Andrea, et al.
Publicado: (2013) -
Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011) -
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)